Research Journal of Pharmacy and Technology

Open Access Open Access  Restricted Access Subscription Access
Open Access Open Access Open Access  Restricted Access Restricted Access Subscription Access

Evaluation of Neuroprotective Activity of Melissa officinalis in MPTP Model of Parkinson’s Disease in Mice


Affiliations
1 Department of Pharmacology, JSS College of Pharmacy (A constituent college of JSS Academy of Higher Education and Research), Ootacamund, The Nilgiris 643 001, India
     

   Subscribe/Renew Journal


The aim of the current study is to evaluate the neuroprotective effect of Melissa officinalis in MPTP model of Parkinson’s disease in mice. The whole plant material was extracted with n-hexane, chloroform, ethyl acetate and ethanol. All the above extracts were assayed for their antioxidant potential by In-vitro DPPH method. The antiparkinson’s activity of ethanolic extract of Melissa officinalis was evaluated by actophotometer and rotarod test. The levels of catalase and SOD were estimated in cortex, cerebellum, hippocampus and striatum. The activity of complex-I was also estimated. Among the four extracts, ethanolic extract showed highest antioxidant potential in DPPH method so it was decided to use ethanolic extract for in-vivo studies. The ethanolic extract of Melissa officinalis showed a significant and dose dependent effect at 100mg/kg and 200mg/kg p.o. in both actophotometer and rotarod model. The ethanolic extract of Melissa officinalis also showed a significant in-vivo antioxidant potential by restoring the levels of catalase and SOD. The results of the present study clearly demonstrate the potential antiparkinson’s properties of the ethanol extract.

Keywords

MPTP, Parkinsons Disease, Melissa officinalis, Complex I, Antioxidants.
Subscription Login to verify subscription
User
Notifications
Font Size


  • Roger D. History of Parkinsonism. Pharmac. Ther 1987; 32: 1 – 17.

  • Alexi T, Borlongan CV, Faull LM, Williams CE, Clark RG, Gluckman PD et al. Neuroprotective strategies for basal ganglia degeneration: Parkinson's and Huntington's diseases. Prog Neurobiology 2000; 60:409-70.

  • Schober A. Classic toxin-induced animal models of Parkinson’s disease: MPTP. Cell Tissue Res 2004; 318:215–24.

  • Bartels AL, Leenders KL. Parkinson’s disease: The syndrome, the pathogenesis and pathophysiology. Cortex 2009; 1 – 7.

  • Moradkhani, Hojat and Sargsyan, Elmira and Bibak, H and Naseri, B and Sadat Hosseini Grouh, Mohammad and Fayazi-Barjin, A and Meftahizade, Heidar. Melissa officinalis L., a valuable medicine plant: A review. Journal of medicinal plant research. 2010;4: 2753-2759.

  • D.O. Kennedya, Andrew B. Scholeya,*, Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm) Pharmacology, Biochemistry and Behavior 72 (2002) 953–964.

  • PrawalPratap Singh Verma. Lemon balm (melissa officinalis l.) An herbal medicinal plant with broad therapeutic uses and cultivation practices: a review. International Journal of Recent Advances in Multidisciplinary Research. (02)11, 0928-0933, 2015.

  • Supritha P and Radha KV. Estimation of Phenolic Compounds Present in the Plant Extracts Using High Pressure Liquid Chromatography, Antioxidant Properties and its Antibacterial Activity.Indian J of Pharmaceutical Education and Research. 2018;52(2):321-6.

  • Patel Rajesh Mand Patel Natvar J. In vitro antioxidant activity of coumarin compounds by DPPH, Super oxide and nitric oxide free radical scavenging methods. Journal of Advanced Pharmacy Education and Research.2011; 1: 52-68.

  • Byahatti VV, Khan AM, Patil SH, Choudhury A. Preliminary Phytochemical Investigation and In-vitro Antioxidant Activity of Bergeniaciliata Leaves. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 399-401.

  • Ahmed H. AL-Azawi, Warqaa Y. Salih, Zainab H. Hassan. Phytochemical and Antioxidant Activity of (Arachishypogaea L.) Skin Extract Scultiv Atedin Iraq. Research J. Pharm. and Tech 2017; 10(11): 3721-3726.

  • Selvakumar K., Madhan R., Srinivasan G., Baskar V. Antioxidant Assays in Pharmacological Research. Asian J. Pharm. Tech. 1(4): Oct. - Dec. 2011; Page 99-103.

  • Rozas G, Guerra MJ, Labandeira-Garcı́a JL. An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Brian Res Protoc. 1997;2:75–84.

  • Bishnoi M, Chopra K, Kulkarni SK (2006) Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes. Eur J Pharmacol 52(1–3):55–66

  • Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thio-barbituric acid reaction. Anal Biochem 95:351–358

  • Kumar E P, Rajan VR, Kumar AD, Parasuraman S, Emerson S F. Hepatoprotective activity of Clearliv a polyherbal formulation in Wistarrats.Arch Med Health Sci 2013;1:120-125

  • Wang HD, Pagano PJ, Du Y, Cayatte AJ, Quinn MT, Brecher P, Cohen RA (1998) Superoxide anion from the adventitia of the rat thoracic aorta inactivates nitric oxide. Circ Res 82:810–818

  • Prithviraj Chakraborty, Suresh Kumar, Debarupa Dutta, Vikas Gupta. Role of Antioxidants in Common Health Diseases. Research J. Pharm. and Tech.2 (2): April.-June. 2009.Page 238-244.

  • 19)Sanap GS, Sawant VA, Shende VS, Shid SL, Borkar SN, Tarannum S, Dama GY, Suresh R. Anti-Hyperglycemic and Antioxidant Activities of the Mehari Choornam. Research J. Pharm. and Tech. 3(2): April- June 2010; Page 402-405.

  • UsharaniS , R. Anuradha. In vivo Antioxidant and Modulating Enzymes of Wattakaka Volubilis and Kaempferol against Aluminium Sulphate Induced in Liver Toxicity. Research J. Pharm. and Tech 2018; 11(7): 2768-2775.

  • Christopher A. Lieu, Allen R. Kunselman A water extract of Mucunapruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias; Parkinsonism and Related Disorders 16 (2010) 458-465

  • Conway KA, Rochet JC, Bieganski RM, Lansbury PT., Jr Kinetic stabilization of the alpha-synucleinprotofibril by a dopamine-alpha-synucleinadduct. Science.2001; 294:1346–1349

  • Martinez-Vicente M, Talloczy Z, Kaushik S, Massey AC, Mazzulli J, Mosharov EV, Hodara R, Fredenburg R, Wu DC, Follenzi A, Dauer W, Przedborski S, Ischiropoulos H, Lansbury PT, Sulzer D, Cuervo AM. Dopamine-modified alpha-synuclein blocks chaperone-mediated autophagy. J Clin Invest. 2008; 118:777–788.

  • S. Bolkent R. Yanardag Protective role of Melissa officinalis L. extract on liver of hyperlipidemic rats: A morphological and biochemical study Journal of Ethnopharmacology; 99 (2005) 391–398.

  • Romaiana Picada Pereiraa, Aline Augusti Boligonc Chemical composition, antioxidant and anticholinesterase activity of Melissa officinalis; Industrial Crops and Products 53 (2014) 34– 45.

  • Prachi Bajpai, Michelle C. Sangar, Metabolism of 1-Methyl-4-phenyl-1-2-3-6 tetrahydropyridine by mitochondria- targeted cytochrome P450 2D6: Implications in Parkinson’s disease. J. biological chemistry 2012; M112.4021-23.

  • Pradeep Sahu, Kiran Sahu, Ravindra Dhar Dubey, Shilpi Chatterjee, Tanushree Chatterjee. Herbal Antioxidants: A Review . Research J. Pharmacognosy and Phytochemistry 2010; 2(6): 427-434.

  • Tandra Das.T. Role of Antioxidants in Health and Diseases-A Review. Research J. Pharm. and Tech. 8(8): August, 2015; Page 1033-1037

  • Rakhi Menon. Antioxidants and their Therapeutic Potential- A Review. Research J. Pharm. and Tech. 6(12): Dec. 2013; Page 1426-1429.

  • M. Vaishali. Antioxidants in Health and Diseases. Research J. Pharm. and Tech. 7(4): April, 2014; Page 489-493.


Abstract Views: 221

PDF Views: 0




  • Evaluation of Neuroprotective Activity of Melissa officinalis in MPTP Model of Parkinson’s Disease in Mice

Abstract Views: 221  |  PDF Views: 0

Authors

P. Rajesh Kumar Reddy
Department of Pharmacology, JSS College of Pharmacy (A constituent college of JSS Academy of Higher Education and Research), Ootacamund, The Nilgiris 643 001, India
J. Saravanan
Department of Pharmacology, JSS College of Pharmacy (A constituent college of JSS Academy of Higher Education and Research), Ootacamund, The Nilgiris 643 001, India
T. K. Praveen
Department of Pharmacology, JSS College of Pharmacy (A constituent college of JSS Academy of Higher Education and Research), Ootacamund, The Nilgiris 643 001, India

Abstract


The aim of the current study is to evaluate the neuroprotective effect of Melissa officinalis in MPTP model of Parkinson’s disease in mice. The whole plant material was extracted with n-hexane, chloroform, ethyl acetate and ethanol. All the above extracts were assayed for their antioxidant potential by In-vitro DPPH method. The antiparkinson’s activity of ethanolic extract of Melissa officinalis was evaluated by actophotometer and rotarod test. The levels of catalase and SOD were estimated in cortex, cerebellum, hippocampus and striatum. The activity of complex-I was also estimated. Among the four extracts, ethanolic extract showed highest antioxidant potential in DPPH method so it was decided to use ethanolic extract for in-vivo studies. The ethanolic extract of Melissa officinalis showed a significant and dose dependent effect at 100mg/kg and 200mg/kg p.o. in both actophotometer and rotarod model. The ethanolic extract of Melissa officinalis also showed a significant in-vivo antioxidant potential by restoring the levels of catalase and SOD. The results of the present study clearly demonstrate the potential antiparkinson’s properties of the ethanol extract.

Keywords


MPTP, Parkinsons Disease, Melissa officinalis, Complex I, Antioxidants.

References